Search clinical trials for: bioindicator
Total 2 results
-
Lijun YangSuzhou Municipal HospitalCompleted
-
University of Turin, ItalyAzienda Ospedaliera Città della Salute e della Scienza di Torino; Azienda Ospedaliero...Unknown
Sponsors and Collaborators
- Monroe Carell Jr. Children's Hospital at Vanderbilt
- Secretariat of Public Education (SEP)
- Clinical Oncology department. Elmansoura University.
- Camille Levy
- Azienda Unità Sanitaria Locale Reggio Emilia
- Jorge Orduña-Valls
- Amira Hussin Hussin Mohammed
- Healthy Life
- Holger Dressel
- Innovative Therapies, Inc.
- Tarek Alsaied
- CellMaxLife
- Ringerike sykehus, Vestre Viken HF
- Institute of Cancer Research (ICR), United Kingdom
- Colorado Childrens Hospital
- Giovanni Mirabella
- Facultad de Estudios Superiores Aragón UNAM
- Ozden Gokcek
- Craving Change
- First People's Hospital of Shenyang
- View Full List
Medical Conditions
- Human Herpes Virus-6 Infection
- Acute Myelogenous Leukemia (AML or ANLL)
- MINI MENTAL STATE EXAMINATION TEST
- Ascorbic Acid
- Body Height
- Post-operative Intercostal Neuralgia
- Triple Negative Breast Cancer, TNBC
- Peripheral Neuropathy Associated With Anti-myelin Associated Glycoprotein Antibodies (Anti-MAG Neuropathy)
- Skin and Subcutaneous Tissue Infection
- Angiotensin-Converting Enzyme Inhibitors
- Postoperative Analgesic Demand
- Ventilator Induced Diaphragm Dysfunction
- Rectal Adenocarcinoma
- Drainage Procedure
- Impulse-Control Disorders
- Established Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD Risk
- Emergency Geriatric Care
- Homologous Recombination Deficient Solid Tumors
- Asthma, Allergic
- CYP2C19 Poor
- View Full List
Drug Interventions
- Leucovorin
- Bevacizumab standard of care
- AMT-101 (oral)
- Standard of care
- Fluvastatin
- RBS2418
- Octreotide
- Trastuzumab
- Ascorbic Acid
- Background regimen (BR) for MDR-TB (multi-drug resistant tuberculosis)
- GW-1000-02
- Antithymocyte globulin (Rabbit)
- Enfuvirtide-intensified HAART
- Tenecteplase
- BMS-770767
- Topical Solution
- AZD7325
- Prolonged release (PR) OROS methylphenidate 72 mg
- Xenon
- Luliconazole Cream 1% - 2 wks
- View Full List
CROs by country
- Contract Research Organizations in Bahrain
- Contract Research Organizations in Burkina Faso
- Contract Research Organizations in Czech Republic
- Contract Research Organizations in El Salvador
- Contract Research Organizations in Estonia
- Contract Research Organizations in Iran
- Contract Research Organizations in Mali
- Contract Research Organizations in Mongolia
- Contract Research Organizations in Pakistan
- Contract Research Organizations in Qatar
- Contract Research Organizations in Rwanda
- Contract Research Organizations in Sweden
- Contract Research Organizations in Venezuela
- CRO list by country